Goodwin Procter advised the underwriters on the deal. Acrivon Therapeutics, Inc. (“Acrivon” or “Acrivon Therapeutics”) (Nasdaq: ACRV), a clinical stage biopharmaceutical company developing precision oncology medicines...
Acrivon Therapeutics’ $99.4 Million Initial Public Offering
Envisagenics’ Research Collaboration Agreement with Bristol Myers Squibb Company
Goodwin Procter advised Envisagenics, Inc. on the deal. Envisagenics, Inc. announced a research collaboration agreement with Bristol Myers Squibb Company (NYSE: BMY). The multi-year collaboration will leverage...
The Boeing Company’s Victory in RICO Class Action Suit
Goodwin Procter advised The Boeing Company on the deal. The Fifth Circuit awarded a complete victory to The Boeing Company, and its co-defendant Southwest Airlines, in a...
AstraZeneca’s Acquisition of Neogene Therapeutics
Cooley advised Neogene Therapeutics on the deal. Neogene Therapeutics, a global clinical-stage biotechnology company, signed its definitive agreement to be acquired by AstraZeneca for a total consideration...
SponsorCX’s Series A Funding Round
Pillsbury Winthrop Shaw Pittman LLP advised Blueprint Equity on the deal. SponsorCX, a leading SaaS sponsorship management platform, secured growth equity financing in a Series A...
Lexitas’ Acquisition of AdvancedONE
Troutman Pepper advised AdvancedONE on the deal. Lexitas, a leading provider of technology-enabled litigation services and a portfolio company of funds advised by Apax, announced its...
TuanChe’s $15 Million Registered Direct Offering
Wilson Sonsini Goodrich & Rosati acted as TuanChe’s U.S. counsel in this transaction. TuanChe Limited, a leading integrated automotive marketplace in China, announced the closing of its...
Cajal Neuroscience’s $96 Million Series A Financing
Wilson Sonsini Goodrich & Rosati advised Cajal Neuroscience on the deal. Cajal Neuroscience Inc., a biotechnology company integrating human genetics, functional genomics, and advanced microscopy to...
Copenhagen Infrastructure Partners’ Investment in Two Biogas Plants
Watson Farley & Williams advised Copenhagen Infrastructure Partners on the deal. Copenhagen Infrastructure Partners, through its CI Advanced Bioenergy Fund I, announced its investment, from the...
Qualitas Energy’s Closing of QEV Fund
King & Wood Mallesons (KWM) has advised Qualitas Energy on the deal. Qualitas Energy, a leading fund manager focused on renewable energy, energy transition and sustainableinfrastructure, announced...
Suzhou Abogen Biosciences Co.’s Establishment and Prosecution of Global Patent Portfolios
Jones Day represented Suzhou Abogen Biosciences Co., Ltd. on the deal. Suzhou Abogen Biosciences Co., Ltd., one of the pioneering biotech companies in China, announced the establishment and...
Armada Parent’s Acquisition of Advanced Marine Preservation
Sheppard Mullin advised Advanced Marine Preservation on the deal. Advanced Marine Preservation (AMP) announced its sale to Armada Parent, Inc. (“Armada”), a portfolio company of global investment...